[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study shall include 50 healthy volunteers eligible for vaccination for COVID-19. These volunteers will be screened for Absolute Lymphocyte Count (CD3+; CD4+ and CD8+) and Anti SARS-CoV-2 spike protein (S1 /S2) IgG. Once vaccinated; they will be divided in two groups: Group A: (N=25) Curvic\u00ae given to vaccinated population for COVID-19 for 120 days Group B: (N=25) Only vaccinated population for COVID-19 Once vaccinated they will follow the protocol for post vaccination. Based on the type of vaccination; whichever is the due date for 2nd vaccination will be followed by the respective volunteer. After completion of 120 days from first dose of vaccination; the volunteers will be again screened for Absolute Lymphocyte Count (CD3+; CD4+ and CD8+) and Anti SARS-CoV-2 spike protein (S1 /S2) IgG in both the groups. SUBJECT RECRUITMENT: Healthy volunteers will be recruited into the study based on the inclusion criteria and the data shall be collected i.e. Demographics; comorbidities; date of vaccination will be entered in excel. They will be closely followed up to 120 days from the first dose of vaccination for COVID-19 to observe for any adverse reactions. RANDOMIZATION: Computer generated randomization DISCONTINUATION CRITERIA: People who become infected during the study period and lost to follow up are excluded.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2452, "treatment_name": "Curvic", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]